US · BME
BlackRock Health Sciences Trust
- Sector
- Financial Services · Asset Management
- Headquarters
- New York City, NY 10055
- Website
- blackrock.com
Price · as of 2024-12-31
$39.39
Market cap 550.83M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $31.98 | -18.81% |
| Intrinsic Value(DCF) | $50.02 | +26.99% |
| Graham-Dodd Method(GD) | $26.18 | -33.54% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $27.67 | ||||
| 2020 | $33.15 | $13.54 | $26.95 | ||
| 2021 | $31.83 | $37.33 | $3.51 | $4.31 | $0.00 |
| 2022 | $32.07 | $95.05 | $0.00 | $0.00 | $281.82 |
| 2023 | $36.63 | $3,438.19 | $53.16 | $11.60 | |
| 2024 | $36.49 | $31.98 | $62.73 | $26.18 | $0.00 |
AI valuation
Our deep-learning model estimates BlackRock Health Sciences Trust's (BME) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $31.98
- Current price
- $39.39
- AI upside
- -18.81%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$50.02
+26.99% upside
Graham-Dodd
$26.18
-33.54% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| BME | BlackRock Health Sciences… | $39.39 | 550.83M | -19% | +27% | -34% | — | 20.62 | 0.63 | 20.09 | 19.46 | 89.98 | 0.63 | 100.00% | 97.44% | 97.44% | 3.46% | 3.53% | 3.42% | 0.00 | 300702.40 | — | — | 0.00 | 2292.00% | -3102.00% | 10463.00% | 13.55% | — | 9.85% | 7.43% | 153.20% | 13.55% | 19.50 | 6.98 | 19.00 | 48.00 |
| BFK | BlackRock Municipal Incom… | $10.09 | 442.5M | +1,094% | +52% | -44% | — | 37.50 | 0.85 | 17.83 | 37.50 | — | 0.85 | 47.85% | 47.53% | 47.53% | 2.24% | 2.21% | 1.42% | 0.00 | 0.91 | 0.30 | 0.30 | 0.00 | -31667.00% | -58657.00% | -6908.00% | 8.47% | 1.42 | 7.03% | 4.87% | 182.60% | 6.23% | 37.50 | 11.81 | 17.83 | 0.81 |
| BGY | BlackRock Enhanced Intern… | $6.19 | 560.9M | +285% | +43% | -99% | -73% | 42.47 | 0.89 | 30.81 | — | — | 0.89 | 100.00% | 54.90% | 72.54% | 1.99% | 1.52% | 1.96% | 0.00 | 385.75 | 0.01 | 0.72 | — | -8554.00% | 536.00% | 4819.00% | 14.26% | 9.86 | 12.16% | 8.21% | 348.80% | 14.26% | 55.68 | 6.96 | 30.57 | 41.63 |
| BHK | BlackRock Core Bond Trust | $9.58 | 518.93M | +225% | +17% | — | — | 55.38 | 0.95 | 51.65 | 33.31 | — | 0.95 | 100.00% | 93.27% | 93.27% | 1.65% | 1.07% | 1.01% | 0.65 | 0.59 | 0.08 | 0.13 | 14.09 | -8235.00% | -8038.00% | -11555.00% | -3.99% | -0.05 | -2.36% | 8.95% | 495.80% | 8.95% | 90.40 | -40.95 | 84.32 | 0.18 |
| BLE | BlackRock Municipal Incom… | $10.54 | 503.04M | +3,324% | +642% | -29% | — | 17.49 | 0.84 | 17.48 | — | — | 0.84 | 100.00% | 99.96% | 99.96% | 4.79% | 3.23% | 3.08% | 0.46 | 2.11 | 0.20 | 0.17 | — | -105082.00% | -195763.00% | 19951.00% | 21.78% | 0.91 | 12.30% | 4.92% | 86.10% | 55.35% | 26.92 | 7.07 | 26.91 | 0.90 |
| BLW | BlackRock Limited Duratio… | $13.66 | 522.26M | +303% | -57% | -91% | -92% | 10.48 | 0.92 | 8.91 | 17.93 | — | 0.92 | 90.74% | 118.05% | 85.01% | 8.84% | 7.68% | 5.33% | 0.66 | 3.58 | 0.13 | 1.03 | 7.46 | -3167.00% | -756.00% | -17081.00% | -5.81% | -1.62 | -3.37% | 9.79% | 102.70% | 9.79% | 12.91 | -29.46 | 15.25 | 0.90 |
| DPG | Duff & Phelps Utility and… | $14.75 | 540.62M | +145% | +65% | -11% | — | 5.56 | 0.90 | 7.16 | 6.63 | — | 0.90 | 88.79% | 142.39% | 128.81% | 16.91% | 14.32% | 12.72% | 0.31 | 10.54 | 0.00 | 0.08 | 1.60 | -3840.00% | -5418.00% | -7423.00% | 2.13% | 0.07 | 1.53% | 6.58% | 36.60% | 17.87% | 6.63 | 61.98 | 9.44 | 2.32 |
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
- CEO
- Charles Choon Sik Park
- Employees
- 0
- Beta
- 0.60
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($50.02 ÷ $39.39) − 1 = +26.99% (DCF, example).